AVROBIO, Inc. Expands Senior Management Team with Three Key Hires

Industry Veterans Bring Deep Industry Experience to Support Future Growth Cambridge, MA, November 9, 2016 – AVROBIO, Inc., a clinical-stage biotechnology company developing transformative, life-changing gene therapies for rare diseases and cancer, today announced the...

AVROBIO Awarded Johnson & Johnson Coveted J-Labs Incubator Space

May 13, 2016 Cambridge, MA May 13, 2016 – AVROBIO, a clinical-stage biotechnology company developing transformative, life-changing gene therapies targeting rare diseases and cancer, today announced it has been awarded lab space at Johnson & Johnson’s (J&J)...